These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2990521)

  • 1. The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasis.
    Camp RD; Mallet AI; Cunningham FM; Wong E; Woollard PM; Dowd P; Kobza Black A; Greaves MW
    Br J Dermatol; 1985 Jul; 113 Suppl 28():98-103. PubMed ID: 2990521
    [No Abstract]   [Full Text] [Related]  

  • 2. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Fogh K; Iversen L; Herlin T; Kragballe K
    Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.
    Kragballe K; Voorhees JJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():12-7. PubMed ID: 3010612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous responses to lipoxygenase products of arachidonic acid.
    Dowd PM; Greaves MW
    Acta Derm Venereol Suppl (Stockh); 1985; 120():18-22. PubMed ID: 3010613
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
    Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
    Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
    Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
    J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzymatic method for distinguishing the stereoisomers of 12-hydroxyeicosatetraenoic acid in human epidermis and psoriatic scale.
    Opas EE; Argenbright LW; Humes JL
    Br J Dermatol; 1989 Jan; 120(1):49-58. PubMed ID: 2517876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of 5-lipoxygenase products in the lung.
    Murphy RC
    Prog Biochem Pharmacol; 1985; 20():84-100. PubMed ID: 2986158
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.
    Duell EA; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1988 Nov; 91(5):446-50. PubMed ID: 2844912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
    Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
    Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
    Kragballe K; Duell EA; Voorhees JJ
    Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monohydroxyeicosatetraenoic acid and leukotriene production by the inflammatory cells of Xenopus laevis.
    Green FA; Herman CA; Herman RP; Claesson HE; Hamberg M
    J Exp Zool; 1987 Aug; 243(2):211-5. PubMed ID: 2821155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.
    Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A
    Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukotrienes and other lipoxygenase products of arachidonic acid synthesized in the kidney.
    Ardaillou R; Baud L; Sraer J
    Am J Med; 1986 Aug; 81(2B):12-22. PubMed ID: 3019135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal 15-hydroxyeicosatetraenoic acid (15-HETE) formation in psoriatic dermis.
    Kragballe K; Duell EA; Voorhees JJ
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():632-6. PubMed ID: 2960169
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
    Camp RD; Fincham NJ
    Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.